CE
CERo Therapeutics Holdings, Inc.
CEROW · OTC
$0.00 +182.35% (+$0.00)
1M +117.65%
Market Cap $101.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 388.91%
ROA 547.09%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.30x
Debt/Equity N/A
Int. coverage N/A
Stability
1 /100
Unstable Beta 0.16x
EPS volatility 7,214.36%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CEROW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Ehrlich
Employees
8
Headquarters
South San Francisco
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report